Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126843891 | 12684389 | 1 | I | 201601 | 20160819 | 20160825 | 20160825 | EXP | FR-AFSSAPS-RE20160793 | FR-VIIV HEALTHCARE LIMITED-FR2016GSK121710 | VIIV | 57.51 | YR | M | Y | 64.00000 | KG | 20160825 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126843891 | 12684389 | 1 | PS | EPIVIR | LAMIVUDINE | 1 | Oral | 150 MG, QD | 20564 | 150 | MG | FILM-COATED TABLET | QD | ||||||
| 126843891 | 12684389 | 2 | SS | VIDEX | DIDANOSINE | 1 | Oral | 400 MG, QD | Y | 0 | 400 | MG | GASTRO-RESISTANT TABLET | QD | |||||
| 126843891 | 12684389 | 3 | C | ISENTRESS | RALTEGRAVIR POTASSIUM | 1 | Oral | 400 MG: 1 DF ON EVEN DAY | 0 | 400 | MG | ||||||||
| 126843891 | 12684389 | 4 | C | WELLVONE | ATOVAQUONE | 1 | Oral | 1 DF IN THE MORNING AND 1 DF IN THE EVENING | 0 | 1 | DF | BID | |||||||
| 126843891 | 12684389 | 5 | C | PROPANOLOL | PROPRANOLOL HYDROCHLORIDE | 1 | Oral | 40 MG, QD IN THE MORNING | 0 | 40 | MG | QD | |||||||
| 126843891 | 12684389 | 6 | C | INEXIUM | ESOMEPRAZOLE | 1 | Oral | 20 MG, QD IN THE EVENING | 0 | 20 | MG | QD | |||||||
| 126843891 | 12684389 | 7 | C | DUPHALAC | LACTULOSE | 1 | Oral | 1 DF, TID | 0 | 1 | DF | TID | |||||||
| 126843891 | 12684389 | 8 | C | UVEDOSE | CHOLECALCIFEROL | 1 | Oral | 1 UNK, EVERY 15 DAYS | 0 | 1 | DF |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126843891 | 12684389 | 1 | HIV infection CDC category A |
| 126843891 | 12684389 | 2 | HIV infection CDC category A |
| 126843891 | 12684389 | 3 | HIV infection CDC category A |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126843891 | 12684389 | HO |
| 126843891 | 12684389 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126843891 | 12684389 | Asthenia | |
| 126843891 | 12684389 | Decreased appetite | |
| 126843891 | 12684389 | Hyperkalaemia | |
| 126843891 | 12684389 | Lactic acidosis | |
| 126843891 | 12684389 | Muscle spasms | |
| 126843891 | 12684389 | Nausea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |